Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Fig 1.

Model constructing workflow.

More »

Fig 1 Expand

Fig 2.

Sequence logo of the region from -30 to +30 in (A) first genes and (B) genes in the operon.

More »

Fig 2 Expand

Fig 3.

Correlation between first genes’ PA/mRNA and their translation rates calculated by the Transim model.

More »

Fig 3 Expand

Fig 4.

The correlation between translation rates and (A) PA/mRNA with mRNA expression level from normalized microarray data and (B) PA.

More »

Fig 4 Expand

Fig 5.

Protein abundance per mRNA for first genes and subsequent genes in the operon.

More »

Fig 5 Expand

Fig 6.

Differences in the expression level of three gene groups with different types of uAUG motif.

More »

Fig 6 Expand

Fig 7.

Effect of features on the coding sequence to the protein expression level per mRNA.

More »

Fig 7 Expand

Fig 8.

The correlation between PA/mRNA and the folding energy in the +1 to +30 region of the mRNAs.

More »

Fig 8 Expand

Fig 9.

Effect of A. Protein sequence length, B. Protein half-life based on N-terminal rules, and C. The instability index (II) of protein.

More »

Fig 9 Expand

Fig 10.

The correlation between PA/mRNA and (A) initiation rates and (B) elongation rates.

More »

Fig 10 Expand

Table 1.

Correlation between new translation rate calculated by different machine learning models and PA/mRNA or PA on A. Testing dataset and B. Total dataset.

More »

Table 1 Expand

Fig 11.

The improved correlation between “New translation rate” and (A) protein expression and (B) protein expression per mRNA.

More »

Fig 11 Expand

Fig 12.

Performance of SVR when predicting (A) protein expression and (B) protein expression per mRNA while integrating every single feature.

More »

Fig 12 Expand

Fig 13.

The best Spearman correlation when combining from 0 to 10 sequential features to the model to predict A. PA/mRNA and B. PA.

More »

Fig 13 Expand